Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Filter articles using the following links
Financial press releases
Events & presentations
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
04 May 2017 - 05 May 2017
4th Annual Retinal Cell & Gene Therapy Innovation Summit, Baltimore (MD)
03 May 2017
GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer
03 May 2017 - 04 May 2017
Deutsche Bank 42nd Annual Health Care Conference, Boston, MA (US)
28 April 2017
GenSight Biologics Announces the Filing of its 2016 Registration Document
27 April 2017
GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit
27 Apr 2017
5th Annual ARM Cell&Gene Investor Day, Boston, MA (US)
22 Apr 2017 - 28 Apr 2017
69th American Academy of Neurology Annual Meeting, Boston, MA (US)
20 April 2017
GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Academy of Neurology
19 April 2017
GenSight Biologics to Attend Upcoming Investor Conferences
01 Apr 2017 - 06 Apr 2017
43rd NANOS Annual Meeting, Washington, DC (US)
View previous 9 articles
1
…
29
30
31
32
33
34
35
36
37
38
39
…
41
View next 9 articles
Go back to the page of the page